MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 03-09-2026
Anixa Biosciences Operating Cash Flow 2011-2026 | ANIX
Annual Operating Cash Flow Anixa Biosciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.17 M | -7.34 M | -6.21 M | -6.49 M | -4.94 M | -6.18 M | -4.74 M | -4.27 M | -3.8 M | -3.38 M | 1.36 M | -2.38 M | -3.19 M | -3.14 M | -716 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.36 M | -7.34 M | -4.17 M |
Quarterly Operating Cash Flow Anixa Biosciences
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.61 M | - | - | - | -2.9 M | - | - | - | -2.31 M | - | - | - | -1.99 M | -4.9 M | - | - | -1.17 M | -3.89 M | -2.41 M | - | -1.91 M | -4.76 M | -3.47 M | - | -1.33 M | -3.4 M | -2.76 M | - | -1.34 M | -3.25 M | -2.08 M | - | -730 K | -3.06 M | -1.81 M | - | -532 K | -2.7 M | -1.88 M | - | 4.65 M | 2.17 M | 2.87 M | - | -1.17 M | -2.02 M | -1.68 M | - | -890 K | -2.64 M | -1.8 M | - | -657 K | -2.18 M | -1.55 M | - | -610 K | -3.51 K | -1.34 M | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 4.65 M | -4.9 M | -1.69 M |
Operating Cash Flow of other stocks in the Diagnostics research industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Burning Rock Biotech Limited
BNR
|
-478 M | $ 16.34 | -1.86 % | $ 179 M |  China |
|
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
1.48 B | $ 111.53 | -2.92 % | $ 33.9 B |  USA |
 |
Castle Biosciences
CSTL
|
64.9 M | $ 23.84 | -3.5 % | $ 662 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-48.7 M | - | -61.36 % | $ 2.46 M | USA |
 |
Aspira Women's Health
AWH
|
-7.03 M | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-8 M | - | - | $ 9.42 M |  Israel |
 |
Co-Diagnostics
CODX
|
-29.1 M | $ 1.58 | -3.07 % | $ 2.1 M | USA |
 |
CareDx, Inc
CDNA
|
42 M | $ 19.79 | -9.68 % | $ 1.05 B | USA |
 |
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | USA |
 |
Enzo Biochem
ENZ
|
-26.3 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
491 M | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
21.1 M | $ 14.8 | -3.27 % | $ 447 M | USA |
 |
Illumina
ILMN
|
837 M | $ 122.56 | -3.44 % | $ 19.5 B | USA |
 |
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
-5.66 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-524 M | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
738 M | $ 165.31 | -0.84 % | $ 8.19 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-18.4 M | - | -20.0 % | $ 1.06 M | USA |
 |
Guardant Health
GH
|
-185 M | $ 80.34 | -3.34 % | $ 10.1 B | USA |
 |
Neogen Corporation
NEOG
|
58.2 M | $ 9.06 | -3.05 % | $ 1.97 B | USA |
 |
Lantheus Holdings
LNTH
|
390 M | $ 81.05 | -2.99 % | $ 5.47 B | USA |
 |
Heska Corporation
HSKA
|
-21.8 M | - | - | $ 1.31 B | USA |
 |
Interpace Biosciences
IDXG
|
5.83 M | $ 1.96 | 1.5 % | $ 8.67 M | USA |
 |
Personalis
PSNL
|
-45.2 M | $ 5.17 | -6.0 % | $ 306 M | USA |
 |
Senseonics Holdings
SENS
|
-59.1 M | $ 6.72 | -6.41 % | $ 280 M | USA |
 |
QIAGEN N.V.
QGEN
|
654 M | - | - | $ 10.6 B |  Niderland |
 |
Medpace Holdings
MEDP
|
713 M | $ 413.73 | 0.97 % | $ 11.9 B | USA |
 |
Biomerica
BMRA
|
-3.84 M | $ 2.16 | -1.22 % | $ 4.96 M | USA |
 |
Trinity Biotech plc
TRIB
|
13.2 M | $ 0.6 | -1.75 % | $ 61.9 M |  Irlanda |
 |
Motus GI Holdings
MOTS
|
-11.2 M | - | -34.28 % | $ 263 K | Israel |
 |
ICON Public Limited Company
ICLR
|
1.29 B | $ 115.5 | 12.69 % | $ 9.53 B | Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
1.64 B | $ 253.28 | -2.41 % | $ 21.1 B | USA |
 |
Twist Bioscience Corporation
TWST
|
-47.6 M | $ 57.4 | -2.96 % | $ 3.43 B | USA |
 |
NeoGenomics
NEO
|
5.23 M | $ 8.45 | -6.32 % | $ 1.08 B | USA |
 |
Celcuity
CELC
|
-153 M | $ 119.85 | -0.18 % | $ 5.6 B | USA |
 |
National Research Corporation
NRC
|
26.4 M | $ 15.97 | -5.17 % | $ 357 M | USA |
 |
Myriad Genetics
MYGN
|
1.8 M | $ 4.64 | -4.03 % | $ 430 M | USA |
 |
Natera
NTRA
|
-432 M | $ 193.57 | -3.3 % | $ 19 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.89 B | $ 187.94 | -3.61 % | $ 20.9 B | USA |
 |
Exagen
XGN
|
-13.6 M | $ 2.66 | -2.56 % | $ 57.3 M | USA |
 |
Invitae Corporation
NVTA
|
-493 M | - | - | $ 21.2 M | USA |
 |
OpGen
OPGN
|
-4.87 M | - | -16.95 % | $ 1.54 M | USA |